MENU
FEB 24, 2021 7:30 AM PST

Keynote Presentation: The biomarker to companion diagnostic continuum: a road map for the delivery of precision medicine

C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract

Specific biomarker assays are included in an increasing number of drug labels, with uses ranging from prediction of adverse events to providing insights on efficacy for patient populations.  More than 40 of these biomarkers fit into the category of companion diagnostics, and provide information on the safety and efficacy of the associated therapy.  The ability to develop biomarker assays in a fit for purpose manner, and then translate that development into a companion diagnostic strategy when appropriate is a key element of the delivery of precision medicine.  In this talk, will cover the key elements necessary for the delivery across this continuum of development, including partnership relationships with pharma and diagnostic companies.  Will also cover future trends include expansion of applications to new therapeutic areas, use of multi-analyte technologies and applications, artificial intelligence and machine learning analytics and algorithms, and implementation of new therapeutic modalities such as cell and gene therapies.

Learning Objectives:

1. Understanding of the key factors in the development of biomarker assays and requirements for transition to companion diagnostic applications

2. Examine future technologies and trends that impact the development of biomarker and companion diagnostic assays and their delivery of precision medicine


Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
MAR 16, 2022 8:00 AM PDT
C.E. CREDITS
MAR 16, 2022 8:00 AM PDT
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
JAN 13, 2022 9:00 AM PST
C.E. CREDITS
JAN 13, 2022 9:00 AM PST
Date: January 13, 2022 Time: 09:00am (PST), 12:00pm (EST) Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug...
FEB 24, 2022 10:00 AM PST
C.E. CREDITS
FEB 24, 2022 10:00 AM PST
Date: February 24, 2021 Time: 10:00am (PST), 1:00pm (EST) One of the largest global public health crises is the rise of antimicrobial-resistant infections. Globally, over 700,000 people die...
Loading Comments...
Show Resources